New study shows advance in CAR T-cell therapy eliminates severe side effects

    Source: Xinhua| 2019-04-23 18:39:02|Editor: xuxin
    Video PlayerClose

    LOS ANGELES, April 23 (Xinhua) -- An advance in the breakthrough cancer treatment known as CAR T-cell therapy appears to eliminate its severe side effects, making the treatment safer and potentially available in outpatient settings, according to a new study of the University of Southern California (USC).

    "This is a major improvement. We've made a new CAR molecule that is just as efficient at killing cancer cells, but it works more slowly and with less toxicity," said Si-Yi Chen of the USC Norris Comprehensive Cancer Center, and senior author of the study appearing online Monday in Nature Medicine.

    This improved version of CAR T therapy produced no serious side effects in 25 patients who had lymphoma that recurred after previous treatments. Although the study was designed to look at safety, not effectiveness, six out of 11 participants receiving a commonly used dose went into complete remission.

    CAR T therapy involves harvesting immune cells called T cells from a patient's blood and then modifying them in the lab to produce special structures called chimeric antigen receptors (CAR) on their surface.

    The altered T cells are reinfused into the patient, where the cells' new receptors enable them to recognize and latch onto cancer cells, killing them.

    Approved by the U.S. Food and Drug Administration less than two years ago, CAR T is a literal lifesaver for some people with leukemia and lymphoma, bringing lasting remissions to those on the brink of death.

    The downside is that the treatment often causes severe side effects -- some of them life-threatening -- which must be managed by experienced specialists.

    In this revised version, researchers tweaked the sequence and shape of the CAR molecules. As a result, the CAR T cells kill cancer cells but produce fewer cytokines and proliferate more slowly, giving the patient's body more time to clear cytokines in the blood.

    "The improved CAR T cells proliferated and differentiated into memory cells in the patients, thus producing a potent and long-lasting anti-tumor effect without causing toxicities," Chen said.

    The research team's next step is to perform a multi-center phase II to test safety and effectiveness in a larger group of patients.

    TOP STORIES
    EDITOR’S CHOICE
    MOST VIEWED
    EXPLORE XINHUANET
    010020070750000000000000011100001380019091
    主站蜘蛛池模板: 污视频app网站| 欧美成人777| 日本免费小视频| 亚洲理论电影在线观看| 色综合久久伊人| 国产精品久久久久久久久齐齐| 一本大道香蕉最新在线视频 | 国产日韩精品一区二区三区| a毛片a毛片a视频| 日产2021乱码一区| 亚洲午夜电影在线观看| 福利在线小视频| 国产不卡在线视频| ww4545四虎永久免费地址| 天天操天天干天天爽| 久久婷婷五月综合色精品| 欧美激情xxx| 免费国产人做人视频在线观看| 高清videosgratis欧洲69| 国产精品高清尿小便嘘嘘| 一二三四视频社区在线| 日本免费大黄在线观看| 亚洲sss综合天堂久久久| 波多野结衣绝顶大高潮| 卡一卡二卡三免费专区2| 鬼作动漫1~6集在线观看| 国产精品毛多多水多| jyzzjyzz国产免费观看| 插插插综合视频| 久久精品国产欧美日韩| 欧美成人精品第一区二区三区| 午夜爽爽爽男女污污污网站| 野花视频在线观看免费观看最新| 国产精品一线二线三线精华液| 99久久人妻无码精品系列| 影音先锋女人aa鲁色资源| 久久亚洲精品无码观看不卡 | 国产在线19禁在线观看| 天堂在线最新资源| 在线观看国产一区| 一区二区三区在线播放视频|